000 01605 a2200445 4500
005 20250514020216.0
264 0 _c20020321
008 200203s 0 0 eng d
022 _a0925-4773
024 7 _a10.1016/s0925-4773(01)00525-1
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aFigueiredo, H F
245 0 0 _aSkin-derived nerve growth factor blocks programmed cell death in the trigeminal ganglia but does not enhance neuron proliferation.
_h[electronic resource]
260 _bMechanisms of development
_cDec 2001
300 _a205-14 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAnimals
650 0 4 _aAntimetabolites, Antineoplastic
_xpharmacology
650 0 4 _aApoptosis
650 0 4 _aBlotting, Western
650 0 4 _aBromodeoxyuridine
_xpharmacology
650 0 4 _aCell Death
650 0 4 _aCell Division
650 0 4 _aIn Situ Nick-End Labeling
650 0 4 _aLigands
650 0 4 _aMice
650 0 4 _aMice, Transgenic
650 0 4 _aNerve Growth Factor
_xmetabolism
650 0 4 _aNeurons
_xcytology
650 0 4 _aProto-Oncogene Proteins c-bcl-2
_xmetabolism
650 0 4 _aRNA, Messenger
_xmetabolism
650 0 4 _aReverse Transcriptase Polymerase Chain Reaction
650 0 4 _aSkin
_xembryology
650 0 4 _aTime Factors
650 0 4 _aTrigeminal Ganglion
_xmetabolism
700 1 _aDavis, B M
700 1 _aAlbers, K M
773 0 _tMechanisms of development
_gvol. 109
_gno. 2
_gp. 205-14
856 4 0 _uhttps://doi.org/10.1016/s0925-4773(01)00525-1
_zAvailable from publisher's website
999 _c11645002
_d11645002